New long-standing metabolites of 17α-methyltestosterone are detected in HepG2 cell in vitro metabolic model and in human urine
- PMID: 37903531
- DOI: 10.1002/dta.3589
New long-standing metabolites of 17α-methyltestosterone are detected in HepG2 cell in vitro metabolic model and in human urine
Abstract
Novel metabolites of the anabolic androgenic steroid 17α-methyltestosterone have been detected in HepG2 cell in vitro metabolic model and in human urine. Their detection was accomplished through targeted gas chromatography-(tandem) mass spectrometry analysis that has been based on microscale synthesized standards. The related synthesis and the gas chromatography-(tandem) mass spectrometry characterization of the analytical standards are described. All newly presented metabolites have a fully reduced steroid A-ring with either an 17,17-dimethyl-18-nor-Δ13 structure or they have been further oxidized at position 16 of the steroid backbone. Metabolites with 17,17-dimethyl-18-nor-Δ13 structure may be considered as side products of phase II metabolic sulfation of the 17β-hydroxy group of methyltestosterone or its reduced tetrahydro-methyltestosterone metabolites 17α-methyl-5β-androstane-3α,17β-diol and 17α-methyl-5α-androstane-3α,17β-diol that produce the known epimeric 17β-methyl-5β-androstane-3α,17α-diol and 17β-methyl-5α-androstane-3α,17α-diol metabolites. The prospective of these new metabolites to increase detection time windows and improve identification was investigated by applying the World Anti-doping Agency TD2021IDCR criteria. The new metabolites, presented herein, complement the current knowledge on the 17α-methyltestosterone metabolism and in some cases can be used as additional long-term markers in the frame of sport doping drug testing.
Keywords: 17α‐methyltestosterone; HepG2; anabolic androgenic steroids; doping control; in vitro metabolism.
© 2023 The Authors. Drug Testing and Analysis published by John Wiley & Sons Ltd.
References
REFERENCES
-
- World Anti‐Doping Agency. 2021 anti‐doping testing figures. Accessed March 26, 2023. https://www.wada-ama.org/sites/default/files/2023-01/2021_antidoping_tes...
-
- Walpurgis K, Piper T, Thevis M. Androgens, sports, and detection strategies for anabolic drug use. Best Pract Res Clin Endocrinol Metab. 2022;36(4):101609. doi:10.1016/j.beem.2021.101609
-
- Schänzer W, Donike M. Metabolism of anabolic steroids in man: synthesis and use of reference substances for identification of anabolic steroid metabolites. Anal Chim Acta. 1993;275(1‐2):23‐48. doi:10.1016/0003‐2670(93)80274‐O
-
- Schänzer W. Metabolism of anabolic androgenic steroids. Clin Chem. 1996;42(7):1001‐1020. doi:10.1093/clinchem/42.7.1001
-
- Van Eenoo P, Delbeke FT. Metabolism and excretion of anabolic steroids in doping control‐new steroids and new insights. J Steroid Biochem Mol Biol. 2006;101(4‐5):161‐178. doi:10.1016/j.jsbmb.2006.06.024
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
